John Lunger

Insider Reports History

Location
Abingdon, Oxfordshire, United Kingdom
Signature
/s/ John Lunger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Lunger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Chief Patient Supply Officer American Depositary Shares representing Ordinary Shares 7,510 $4,362 $0.5808 17 Jan 2025 Direct
Adaptimmune Therapeutics PLC Chief Patient Supply Officer Option to purchase Ordinary Shares 1,074,696 20 Feb 2025 Direct
GENOCEA BIOSCIENCES, INC. Director Stock Option (Right to Buy) 30,000 03 Mar 2022 Direct

Insider Reports Filed by John Lunger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADAP Adaptimmune Therapeutics PLC 20 Feb 2025 2 $0 4 Chief Patient Supply Officer 20 Feb 2025, 17:33
ADAP Adaptimmune Therapeutics PLC 17 Jan 2025 1 -$3,243 4 Chief Patient Supply Officer 17 Jan 2025, 21:17
ADAP Adaptimmune Therapeutics PLC 13 Jan 2025 3 -$11,360 4 Chief Patient Supply Officer 15 Jan 2025, 16:16
ADAP Adaptimmune Therapeutics PLC 16 Jan 2024 3 -$15,889 4 Chief Patient Supply Officer 17 Jan 2024, 17:30
ADAP Adaptimmune Therapeutics PLC 15 Jan 2024 2 $0 4 Chief Patient Supply Officer 17 Jan 2024, 17:02
ADAP Adaptimmune Therapeutics PLC 11 Jan 2024 2 -$7,813 4 Chief Patient Supply Officer 12 Jan 2024, 17:00
ADAP Adaptimmune Therapeutics PLC 01 Aug 2023 1 -$2,804 4 Chief Patient Supply Officer 01 Aug 2023, 17:00
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 1 -$8,250 4 Chief Patient Supply Officer 17 Jan 2023, 20:17
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 3 $0 4 Chief Patient Supply Officer 17 Jan 2023, 20:06
ADAP Adaptimmune Therapeutics PLC 11 Jan 2023 2 -$15,197 4 Chief Patient Supply Officer 12 Jan 2023, 20:02
ADAP Adaptimmune Therapeutics PLC 04 Jan 2023 1 -$1,863 4 Chief Patient Supply Officer 04 Jan 2023, 20:01
ADAP Adaptimmune Therapeutics PLC 01 Aug 2022 1 -$5,290 4 Chief Patient Supply Officer 01 Aug 2022, 21:01
ADAP Adaptimmune Therapeutics PLC 05 Jul 2022 1 -$3,311 4 Chief Patient Supply Officer 05 Jul 2022, 21:00
/report/000145761222000009-lunger-john-2022-03-03 GENOCEA BIOSCIENCES, INC. 03 Mar 2022 1 $0 4 Director 07 Mar 2022, 17:14
/report/000145761222000008-lunger-john-2022-03-03 GENOCEA BIOSCIENCES, INC. 03 Mar 2022 0 $0 3 Director 07 Mar 2022, 15:51
ADAP Adaptimmune Therapeutics PLC 18 Jan 2022 1 -$13,942 4 Chief Patient Supply Officer 18 Jan 2022, 20:03
ADAP Adaptimmune Therapeutics PLC 12 Jan 2022 2 $0 4 Chief Patient Supply Officer 13 Jan 2022, 20:04
ADAP Adaptimmune Therapeutics PLC 11 Jan 2022 2 -$17,222 4 Chief Patient Supply Officer 13 Jan 2022, 20:02
ADAP Adaptimmune Therapeutics PLC 04 Jan 2022 1 -$4,349 4 Chief Patient Supply Officer 05 Jan 2022, 20:06
ADAP Adaptimmune Therapeutics PLC 02 Aug 2021 1 -$10,536 4 Chief Patient Supply Officer 02 Aug 2021, 17:09
ADAP Adaptimmune Therapeutics PLC 02 Jul 2021 1 -$8,133 4 Chief Patient Supply Officer 02 Jul 2021, 20:01